BIOVENTUS INC - A (BVS) Fundamental Analysis & Valuation
NASDAQ:BVS • US09075A1088
8.47 USD
-0.27 (-3.09%)
At close: Mar 4, 2026
9.05 USD
+0.58 (+6.85%)
Pre-Market: 3/5/2026, 7:00:11 AM
This BVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
BVS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. BVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.
1. BVS Profitability Analysis
1.1 Basic Checks
- BVS had positive earnings in the past year.
- In the past year BVS had a positive cash flow from operations.
- In multiple years BVS reported negative net income over the last 5 years.
- BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- BVS has a Return On Assets of 1.11%. This is in the better half of the industry: BVS outperforms 73.91% of its industry peers.
- BVS has a Return On Equity of 4.71%. This is in the better half of the industry: BVS outperforms 77.17% of its industry peers.
- With an excellent Return On Invested Capital value of 6.62%, BVS belongs to the best of the industry, outperforming 80.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 1.39%, BVS is doing good in the industry, outperforming 73.37% of the companies in the same industry.
- With a decent Operating Margin value of 8.03%, BVS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of BVS has declined.
- The Gross Margin of BVS (67.76%) is better than 73.37% of its industry peers.
- BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. BVS Health Analysis
2.1 Basic Checks
- BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, BVS has more shares outstanding
- Compared to 5 years ago, BVS has more shares outstanding
- Compared to 1 year ago, BVS has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.31, we must say that BVS is in the distress zone and has some risk of bankruptcy.
- BVS has a Altman-Z score of 1.31. This is comparable to the rest of the industry: BVS outperforms 54.35% of its industry peers.
- The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 6.22, BVS is doing good in the industry, outperforming 76.63% of the companies in the same industry.
- BVS has a Debt/Equity ratio of 1.93. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.93, BVS is doing worse than 81.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.31 |
ROIC/WACC0.6
WACC10.98%
2.3 Liquidity
- BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.74, BVS is not doing good in the industry: 67.93% of the companies in the same industry are doing better.
- A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
- BVS has a Quick ratio of 1.14. This is in the lower half of the industry: BVS underperforms 71.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. BVS Growth Analysis
3.1 Past
- BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
- The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
- BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.58%.
- Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
- BVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.45% yearly.
- Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 5.25% on average per year.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5Y17.45%
Revenue Next Year0.15%
Revenue Next 2Y3.42%
Revenue Next 3Y4.42%
Revenue Next 5Y5.25%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. BVS Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 14.36, the valuation of BVS can be described as correct.
- 89.67% of the companies in the same industry are more expensive than BVS, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (27.03), we can say BVS is valued slightly cheaper.
- With a Price/Forward Earnings ratio of 10.55, the valuation of BVS can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 94.02% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.11. BVS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.36 | ||
| Fwd PE | 10.55 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaply inside the industry as 91.30% of the companies are valued more expensively.
- BVS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BVS is cheaper than 97.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.11 | ||
| EV/EBITDA | 10.66 |
4.3 Compensation for Growth
- BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as BVS's earnings are expected to grow with 25.05% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%
5. BVS Dividend Analysis
5.1 Amount
- No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BVS Fundamentals: All Metrics, Ratios and Statistics
8.47
-0.27 (-3.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-05 2026-03-05/bmo
Inst Owners74.45%
Inst Owner Change2.28%
Ins Owners2.5%
Ins Owner Change0.55%
Market Cap700.98M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target14.79 (74.62%)
Short Float %2.63%
Short Ratio6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)-3.33%
PT rev (3m)-3.33%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.36 | ||
| Fwd PE | 10.55 | ||
| P/S | 1.24 | ||
| P/FCF | 13.11 | ||
| P/OCF | 12.51 | ||
| P/B | 4.22 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.66 |
EPS(TTM)0.59
EY6.97%
EPS(NY)0.8
Fwd EY9.48%
FCF(TTM)0.65
FCFY7.63%
OCF(TTM)0.68
OCFY7.99%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.34
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.31 |
F-Score8
WACC10.98%
ROIC/WACC0.6
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5Y17.45%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.15%
Revenue Next 2Y3.42%
Revenue Next 3Y4.42%
Revenue Next 5Y5.25%
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.93%
EBIT Next 3Y12.11%
EBIT Next 5Y10.4%
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status for BVS stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 14.36 and the Price/Book (PB) ratio is 4.22.
What is the financial health of BIOVENTUS INC - A (BVS) stock?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.